Triphenylphosphine → 4-(3-Ethoxyphenyl)-1-(2-{[6-(trifluoromethyl)pyridin-3-yl]oxy}ethyl)-1H-pyrrolo[3,2-c]pyridine-2-carboxylic acid

HRID 513190ノート

反応式

HRID 513190 の反応式
[CH2:1]([O:3][C:4]1[CH:5]=[C:6]([C:10]2[C:15]3[CH:16]=[C:17]([C:22]([O:24]C)=[O:23])[N:18]([CH2:19][CH2:20][OH:21])[C:14]=3[CH:13]=[CH:12][N:11]=2)[CH:7]=[CH:8][CH:9]=1)[CH3:2].[F:26][C:27]([F:36])([F:35])[C:28]1[N:33]=[CH:32][C:31](O)=[CH:30][CH:29]=1.C1C=CC(P(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.CC(OC(/N=N/C(OC(C)C)=O)=O)C.[OH-].[Na+]>C1COCC1>[CH2:1]([O:3][C:4]1[CH:5]=[C:6]([C:10]2[C:15]3[CH:16]=[C:17]([C:22]([OH:24])=[O:23])[N:18]([CH2:19][CH2:20][O:21][C:31]4[CH:32]=[N:33][C:28]([C:27]([F:36])([F:35])[F:26])=[CH:29][CH:30]=4)[C:14]=3[CH:13]=[CH:12][N:11]=2)[CH:7]=[CH:8][CH:9]=1)[CH3:2]

参加物

7

反応物 5

HCID 11776TriphenylphosphineHCID 14798Sodium HydroxideHCID 27833885-Hydroxy-2-(trifluoromethyl)pyridineHCID 5363146Diisopropyl azodicarboxylateHCID 71212676Methyl 4-(3-ethoxyphenyl)-1-(2-hydroxyethyl)-1H-pyrrolo[3,2-c]pyridine-2-carboxylate

生成物 1

HCID 712126154-(3-Ethoxyphenyl)-1-(2-{[6-(trifluoromethyl)pyridin-3-yl]oxy}ethyl)-1H-pyrrolo[3,2-c]pyridine-2-carboxylic acid収率 94%

試薬・触媒・溶媒 1

HCID 8028Tetrahydrofuran溶媒

反応条件

温度
60 °C

実験手順

Methyl 4-(3-ethoxyphenyl)-1-(2-hydroxyethyl)-1H-pyrrolo[3,2-c]pyridine-2-carboxylate (30 mg, 0.088 mmole), 6-(trifluoromethyl)pyridine-3-ol (19 mg, 0.116 mmole), and PS-triphenylphosphine resin (116 mg, 0.264 mmole) were combined in a screw cap vial. To this was added THF (1 mL) and DIAD (0.022 mL, 0.115 mmole) at RT. After stirring overnight the mixture was filtered washing with CH2Cl2 and concentrated. The residue was taken up in THF (1 mL). To this was added 2M NaOH (0.132 mL, 0.264 mmole) then the mixture was heated to 60° C. After 3 hr the mixture was cooled to RT and concentrated. The crude material was taken up in DMSO and acidified with TFA. The resulting solution was purified by preparative reversed-phase HPLC (21×100 mm Phenomenex AXIA-Gemini-NX, 15%-40% CH3CN/water containing 0.1% TFA over 18 min at 20 mL/min) to give the title compound (39 mg, 76%) as a white solid. 1H NMR (499 MHz, DMSO): δ 8.57 (d, J=6.7 Hz, 1 H); 8.46 (s, 1 H); 8.19 (s, 1H); 7.99 (d, J=8.8 Hz, 1 H); 7.63-7.55 (m, 2 H); 7.48-7.44 (m, 2 H); 7.27 (d, J=8.2 Hz, 1 H); 6.79 (d, J=8.7 Hz, 1 H); 5.18 (m, 2 H); 4.80 (m, 2 H); 4.16 (q, J=7.0 Hz, 2 H); 1.38 (t, J=6.9 Hz, 3 H). HRMS (ESI) calc (M+H)+=472.1479. found 472.1459.

後処理

  1. customcap vial
  2. filtrationwas filtered
  3. washwashing with CH2Cl2
  4. concentrationconcentrated
  5. temperatureAfter 3 hr the mixture was cooled to RT
  6. concentrationconcentrated
  7. customThe resulting solution was purified by preparative reversed-phase HPLC (21×100 mm Phenomenex AXIA-Gemini-NX, 15%-40% CH3CN/water containing 0.1% TFA over 18 min at 20 mL/min)

出典と根拠

ORDレコード
ord-eba743be4ec64c04a1164d3a3742fab4
出典データセット
uspto-grants-2015_08
特許番号
US09102673B2

反応ノート

読み込み中…